电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

DCK 抗体

This anti-DCK antibody is a 小鼠 单克隆 antibody detecting DCK in WB 和 FACS. Suitable for 人.
产品编号 ABIN2719385
发货至: 中国

Quick Overview for DCK 抗体 (ABIN2719385)

抗原

See all DCK 抗体
DCK (Deoxycytidine Kinase (DCK))

适用

  • 51
  • 27
  • 14
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

宿主

  • 38
  • 13
  • 3
小鼠

克隆类型

  • 43
  • 11
单克隆

标记

  • 36
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DCK antibody is un-conjugated

应用范围

  • 38
  • 22
  • 22
  • 20
  • 18
  • 11
  • 10
  • 6
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

克隆位点

16E12
  • 产品特性

    Homo sapiens deoxycytidine kinase (DCK)

    纯化方法

    Purified from mouse ascites fluids by affinity chromatography

    免疫原

    Full length human recombinant protein of human DCK (NP_000779) produced in HEK293T cell.

    亚型

    IgG1
  • 应用备注

    WB 1:2000, FLOW 1:100

    说明

    The concentration of the product may vary between diferrent lots.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    0.5-1.0 mg/mL

    缓冲液

    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C
  • 抗原

    DCK (Deoxycytidine Kinase (DCK))

    别名

    DCK

    背景

    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

    分子量

    30.3 kDa

    基因ID

    1633

    NCBI登录号

    NM_000788

    HGNC

    1633
You are here:
Chat with us!